Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy.

Holmes LB, Baldwin EJ, Smith CR, Habecker E, Glassman L, Wong SL, Wyszynski DF.

Neurology. 2008 May 27;70(22 Pt 2):2152-8. doi: 10.1212/01.wnl.0000304343.45104.d6. Epub 2008 Apr 30. Erratum in: Neurology. 2009 Apr 21;72(16):1449.

PMID:
18448870
2.

Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.

Holmes LB, Mittendorf R, Shen A, Smith CR, Hernandez-Diaz S.

Arch Neurol. 2011 Oct;68(10):1275-81. doi: 10.1001/archneurol.2011.133. Epub 2011 Jun 13.

PMID:
21670385
3.

Newer anticonvulsants: lamotrigine, topiramate and gabapentin.

Holmes LB, Hernandez-Diaz S.

Birth Defects Res A Clin Mol Teratol. 2012 Aug;94(8):599-606. doi: 10.1002/bdra.23028. Epub 2012 Jun 22.

PMID:
22730257
4.

Comparative safety of antiepileptic drugs during pregnancy.

Hernández-Díaz S, Smith CR, Shen A, Mittendorf R, Hauser WA, Yerby M, Holmes LB; North American AED Pregnancy Registry; North American AED Pregnancy Registry.

Neurology. 2012 May 22;78(21):1692-9. doi: 10.1212/WNL.0b013e3182574f39. Epub 2012 May 2.

PMID:
22551726
5.

Preliminary results on pregnancy outcomes in women using lamotrigine.

Tennis P, Eldridge RR; International Lamotrigine Pregnancy Registry Scientific Advisory Committee.

Epilepsia. 2002 Oct;43(10):1161-7.

6.

Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies.

Dolk H, Wang H, Loane M, Morris J, Garne E, Addor MC, Arriola L, Bakker M, Barisic I, Doray B, Gatt M, Kallen K, Khoshnood B, Klungsoyr K, Lahesmaa-Korpinen AM, Latos-Bielenska A, Mejnartowicz JP, Nelen V, Neville A, O'Mahony M, Pierini A, Rißmann A, Tucker D, Wellesley D, Wiesel A, de Jong-van den Berg LT.

Neurology. 2016 May 3;86(18):1716-25. doi: 10.1212/WNL.0000000000002540. Epub 2016 Apr 6.

7.

Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?

Dolk H, Jentink J, Loane M, Morris J, de Jong-van den Berg LT; EUROCAT Antiepileptic Drug Working Group.

Neurology. 2008 Sep 2;71(10):714-22. doi: 10.1212/01.wnl.0000316194.98475.d8. Epub 2008 Jul 23.

PMID:
18650491
8.

Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.

Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Sabers A, Perucca E, Vajda F; EURAP study group.

Lancet Neurol. 2011 Jul;10(7):609-17. doi: 10.1016/S1474-4422(11)70107-7. Epub 2011 Jun 5.

PMID:
21652013
9.

Increased rate of major malformations in offspring exposed to valproate during pregnancy.

Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB; Antiepileptic Drug Pregnancy Registry.

Neurology. 2005 Mar 22;64(6):961-5.

PMID:
15781808
10.

Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy.

Hunt SJ, Craig JJ, Morrow JI.

Neurology. 2009 Mar 24;72(12):1108; author reply 1108-9. doi: 10.1212/01.wnl.0000346463.44116.56. No abstract available.

PMID:
19307550
11.
12.

Lamotrigine and the risk of malformations in pregnancy.

Cunnington M, Tennis P; International Lamotrigine Pregnancy Registry Scientific Advisory Committee.

Neurology. 2005 Mar 22;64(6):955-60.

PMID:
15781807
13.

Valproic acid monotherapy in pregnancy and major congenital malformations.

Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, de Jong-van den Berg LT; EUROCAT Antiepileptic Study Working Group.

N Engl J Med. 2010 Jun 10;362(23):2185-93. doi: 10.1056/NEJMoa0907328. Review.

14.

Teratogenicity of lamotrigine.

Shor S, Koren G, Nulman I.

Can Fam Physician. 2007 Jun;53(6):1007-9.

15.

Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study.

Jentink J, Dolk H, Loane MA, Morris JK, Wellesley D, Garne E, de Jong-van den Berg L; EUROCAT Antiepileptic Study Working Group.

BMJ. 2010 Dec 2;341:c6581. doi: 10.1136/bmj.c6581. Review.

16.

Utilization of topiramate during pregnancy and risk of birth defects.

Green MW, Seeger JD, Peterson C, Bhattacharyya A.

Headache. 2012 Jul-Aug;52(7):1070-84. doi: 10.1111/j.1526-4610.2012.02190.x. Epub 2012 Jun 22.

PMID:
22724387
17.

Final results from 18 years of the International Lamotrigine Pregnancy Registry.

Cunnington MC, Weil JG, Messenheimer JA, Ferber S, Yerby M, Tennis P.

Neurology. 2011 May 24;76(21):1817-23. doi: 10.1212/WNL.0b013e31821ccd18.

PMID:
21606453
18.
19.

Maternal drug use and infant cleft lip/palate with special reference to corticoids.

Källén B.

Cleft Palate Craniofac J. 2003 Nov;40(6):624-8.

PMID:
14577813
20.

Topiramate use in pregnancy and the birth prevalence of oral clefts.

Mines D, Tennis P, Curkendall SM, Li DK, Peterson C, Andrews EB, Calingaert B, Chen H, Deshpande G, Esposito DB, Everage N, Holick CN, Meyer NM, Nkhoma ET, Quinn S, Rothman KJ, Chan KA.

Pharmacoepidemiol Drug Saf. 2014 Oct;23(10):1017-25. doi: 10.1002/pds.3612. Epub 2014 Apr 1.

PMID:
24692316

Supplemental Content

Support Center